Funded Tech Companies

Labrys Biologics

Headquartered in San Francisco, Labrys Biologics has funding from venBio, Canaan Partners and InterWest Partners.

Company Overview

Company Name
Labrys Biologics
Company Status
Acquired or Merged
Funding Rounds

Contact Information

Mailing Address
1700 Owens Street 595
San Francisco, CA 94158
Email Address
Not Recorded

Company Background Information

Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine. Labrys' lead candidate, RN-307, is an anti-CGRP monoclonal antibody for the treatment of chronic migraine slated to enter Phase 2 clinical trials in 2013.
Labrys Biologics LinkedIn Company Profile
Social Media
Labrys Biologics Company Twitter Account
Company News
Labrys Biologics News
Labrys Biologics on Facebook
Labrys Biologics on YouTube
Last Transaction

Financing History

Venture Equity

Management Team

Email & Social
Chief Executive Officer
Steven James
  Steven James LinkedIn Profile  Steven James Twitter Account  Steven James News  Steven James on Facebook
Chief Medical Officer
Marcelo Bigal
  Marcelo Bigal LinkedIn Profile  Marcelo Bigal Twitter Account  Marcelo Bigal News  Marcelo Bigal on Facebook
VP - Product Management
Michael Chang
  Michael Chang LinkedIn Profile  Michael Chang Twitter Account  Michael Chang News  Michael Chang on Facebook
VP - Regulatory Affairs
Michele Bronson
  Michele Bronson LinkedIn Profile  Michele Bronson Twitter Account  Michele Bronson News  Michele Bronson on Facebook

Company Investors




Browse more funded tech companies:

Labrador Systems | Labrys Technologies


Share this article


About Our Venture Capital Database

This tech company profile is powered by, a leading provider of venture capital transaction data.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary